Taking certain cholesterol drugs called evolocumab or alirocumab may help lower the chance of heart problems, whether you've already had heart issues or are just trying to prevent them.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
Taking certain cholesterol drugs called evolocumab or alirocumab may help lower the chance of heart problems, whether you've already had heart issues or are just trying to prevent them.
See the technical phrasing
The use of evolocumab or alirocumab is associated with a reduced risk of cardiovascular events in both primary and secondary prevention settings, with reported relative risks of 0.818 and 0.725 respectively, suggesting consistent benefit regardless of baseline cardiovascular disease status.
What the research says
Supports
1 study
Study: Primary and secondary prevention of stroke and cardiovascular events using evolocumab and alirocumab: Meta-analysis of randomized controlled trials.
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies